Reproductive disturbances, pituitary lactotrope adenomas, and mammary gland tumors in transgenic female mice producing high levels of human chorionic gonadotropin

Endocrinology

Volumn 143, Issue 10, 2002, Pages 4084-4095

  Rulli, Susana B ^a   Kuorelahti, Aino ^a   Karaer, Öznur ^a   Pelliniemi, Lauri J ^a   Poutanen, Matti ^a   Huhtaniemi, Ilpo ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; COMPLEMENTARY DNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BETA CHAIN; BREAST ADENOCARCINOMA; BREAST TUMOR; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HYPERPROLACTINEMIA; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; INFERTILITY; MALE; MOUSE; NONHUMAN; OVARIECTOMY; OVARY FUNCTION; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; REPRODUCTION; STEROIDOGENESIS; TRANSGENIC MOUSE; UTERUS MALFORMATION;

ADENOMA; ANIMALS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENITALIA, FEMALE; HORMONES; HUMANS; HYPERPROLACTINEMIA; INFERTILITY; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; OBESITY; OVARY; PITUITARY GLAND, ANTERIOR; PITUITARY NEOPLASMS; PROLACTIN;

EID: 0036772574     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-220490     Document Type: Article

References (59)

1. Gharib SD, Wierman ME, Shupnik MA, Chin WW 1990 Molecular biology of the pituitary gonadotropins. Endocr Rev 1.1:177-199
2. Rao CV 1996 The beginning of a new era in reproductive biology and medicine: Expression of low levels of functional luteinizing hormone/human chorionic gonadotropin receptors in non-gonadal tissues. J Physiol Pharmacol 47(Suppl 1):41-53
3. Kero J, Poutanen M, Zhang FP, Rahman N, McNicol AM, Nilson JH, Keri RA, Huhtaniemi IT 2000 Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex. J Clin Invest 105:633-641
4. Themmen APN, Huhtaniemi IT 2000 Mutations of gonadotropins and gonadotropin receptors: Elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev 21:551-583
5. Cramer DW, Welch WR 1983 Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 71:717-721
6. Franks S 1995 Polycystic ovary syndrome. N Engl J Med 333:853-861
7. Russo IH, Russo J 1998 Role of hormones in mammary cancer initiation and progression. J Mammary Gland Biol Neoplasia 3:49-61
8. Risch HA 1998 Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 90:1774-1786
9. Kumar TR, Palapattu G, Wang P, Woodruff TK, Boime I, Byrne MC, Matzuk MM 1999 Transgenic models to study gonadotropin function: The role of follicle-stimulating hormone in gonadal growth and tumorigenesis. Mol Endocrinol 13:851-865
10. Risma KA, Clay CM, Nett TM, Wagner T, Yun J, Nilson JH 1995 Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proc Natl Acad Sci USA 92:1322-1326
11. Keri RA, Lozada KL, Abdul-Karim FW, Nadeau JH, Nilson JH 2000 Luteinizing hormone induction of ovarian tumors: Oligogenic differences between mouse strains dictates tumor disposition. Proc Natl Acad Sci USA 97: 383-387
12. Nilson JH, Abbud RA, Keri RA, Quirk CC 2000 Chronic hypersecretion of luteinizing hormone in transgenic mice disrupts both ovarian and pituitary function, with some effects modified by the genetic background. Recent Prog Horm Res 55:69-89
13. Kananen K, Rilianawati, Paukku T, Markkula M, Rainio EM, Huhtanemi IT 1997 Suppression of gonadotropins inhibits gonadal tumorigenesis in mice transgenic for the mouse inhibin α-subunit promoter/simian virus 40 Tantigen fusion gene. Endocrinology 138:3521-3531
14. Rilianawati, Paukku T, Kero J, Zhang FP, Rahman N, Kananen K, Huhtaniemi IT 1998 Direct luteinizing hormone action triggers adrenocortical tumorigenesis in castrated mice transgenic for the murine inhibin α-subunit promoter/simian virus 40 T-antigen fusion gene. Mol Endocrinol 12:801-809
15. Zhang FP, Poutanen M, Wilbertz J, Huhtaniemi IT 2001 Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. Mol Endocrinol 15:172-183
16. Lei ZM, Mishra S, Zou W, Xu B, Foltz M, Li X, Rao CV 2001 Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene. Mol Endocrinol 15:184-200
17. Fiddes JC, Goodman, HM 1980 The cDNA for the beta-subunit of human chorionic gonadotropin suggests evolution of a gene by readthrough into the 3′-untranslated region. Nature 286:684-687
18. Van Casteren JI, Schoonen WG, Kloosterboer HJ 2000 Development of timeresolved immunofluorometric assays for rat follicle-stimulating hormone and luteinizing hormone and application on sera of cycling rats. Biol Reprod 62:886-894
19. Bergendahl M, Perheentupa A, Huhtaniemi IT 1989 Effect of short-term starvation on reproductive hormone gene expression, secretion and receptor levels in male rats. J Endocrinol 121:409-417
20. Huhtaniemi I, Nikula H, Rannikko S 1985 Treatment of prostatic cancer with a gonadotropin-releasing hormone agonist analog: Acute and long term effects on endocrine functions of testis tissue. J Clin Endocrinol Metab 61:698-704
21. Vuorento T, Lahti A, Hovatta O, Huhtaniemi IT 1988 Daily measurements of salivary progesterone reveal a high rate of anovulation in healthy students. Scand J Clin Lab Invest 49:395-401
22. Ding YQ, Huhtaniemi IT 1989 Human serum LH inhibitor(s): Behaviour and contribution to in vitro bioassay of LH using dispersed mouse Leydig cells. Acta Endocrinol (Copenh) 121:46-54
23. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
24. Sundström J, Pelliniemi LJ, Kuopio T, Veräjänkorva E, Fröjdman K, Harley V, Salminen E, Pöllänen P 1999 Characterization of the model for experimental testicular teratoma in 129/SvJ-mice. Br J Cancer 80:149-160
25. Schorpp M, Jager R, Schellander K, Schenkel J, Wagner EF, Weiher H, Angel P 1996 The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice. Nucleic Acids Res 24:1787-1788
26. Kendall SK, Gordon DF, Birkmeier TS, Petrey D, Sarapura VD, O-Shea KS, Wood WM, Lloyd RV, Ridgway EC, Camper SA 1994 Enhancer-mediated high level expression of mouse pituitary glycoprotein hormone α-subunit transgene in thyrotropes, gonadotropes, and developing pituitary gland. Mol Endocrinol 8:1420-1433
27. Markkula M, Hämäläinen T, Loune E, Huhtaniemi I 1995 The follicle-stimulating hormone (FSH) β- and common α-subunits are expressed in mouse testis, as determined in wild-type mice and those transgenic for the FSH β-subunit/herpes simplex virus thymidine kinase fusion gene. Endocrinology 136:4769-4775
28. Combarnous Y 1992 Molecular basis of the specificity of binding of glycoprotein hormones to their receptors. Endocr Rev 13:670-691
29. Richards JS 1980 Maturation of ovarian follicles: Actions and interactions of pituitary and ovarian hormones on follicular cell differentiation. Physiol Rev 60:51-89
30. Richards JS 1994 Hormonal control of gene expression in the ovary. Endocr Rev 15:725-751
31. Freeman ME, Kanyicska B, Lerant A, Nagy G 2000 Prolactin: Structure, function, and regulation of secretion. Physiol Rev 80:1523-1631
32. Risma KA, Hirshfield AN, Nilson JH 1997 Elevated luteinizing hormone in prepubertal transgenic mice causes hyperandrogenemia, precocious puberty, and substantial ovarian pathology. Endocrinology 138:3540-3547
33. Mann RJ, Keri RA, Nilson JH 1999 Transgenic mice with chronically elevated luteinizing hormone are infertile due to anovulation, defects in uterine receptivity, and midgestation pregnancy failure. Endocrinology 140:2592-2601
34. Abbud RA, Ameduri RK, Rao JS, Nett TM, Nilson JH 1999 Chronic hypersecretion of luteinizing hormone in transgenic mice selectively alters responsiveness of the α-subunit gene to gonadotropin-releasing hormone and estrogens. Mol Endocrinol 13:1449-1459
35. Ichihara I 1969 Electron microscopic studies of anterior pituitary glands of vitamin E-deficient male mice. J Anat 104:455-465
36. Stefaneanu L, Powell-Braxton L, Won W, Chandrashekar V, Bartke A 1999 Somatotroph and lactotroph changes in the adenohypophyses of mice with disrupted insulin-like growth factor I gene. Endocrinology 140:3881-3889
37. McAndrew J, Paterson AJ, Asa SL, McCarthy KJ, Kudlow JE 1995 Targeting of transforming growth factor-α expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas. Endocrinology 136:4479-4488
38. Asa SL, Kovacs K, Stefaneanu L, Horvath E, Billestrup N, Gonzalez Manchon C, Vale W 1992 Pituitary adenomas in mice transgenic for growth hormone-releasing hormone. Endocrinology 131:2083-2089
39. Asa SL, Kelly MA, Grandy DK, Low MJ 1999 Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice. Endocrinology 140:5348-5355
40. Asa SL, Ezzat S 1998 The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 19:798-827
41. Heaney AP, Horwitz GA, Wang Z, Singson R, Melmed S 1999 Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat Med 5:1317-1321
42. Spady TJ, Harvell DM, Snyder MC, Pennington KL, McComb RD, Shull JD 1998 Estrogen-induced tumorigenesis in the Copenhagen rat: Disparate susceptibilities to development of prolactin-producing pituitary tumors and mammary carcinomas. Cancer Lett 124:95-103
43. Asa SL, Penz G, Kovacs K, Ezrin C 1982 Prolactin cells in the human pituitary. A quantitative immunocytochemical analysis. Arch Pathol Lab Med 106:360-363
44. Scheithauer BW, Sano T, Kovacs KT, Young WF, Ryan N, Randall RV 1990 The pituitary gland in pregnancy: A clinicopathologic and immunohistochemical study of 69 cases. Mayo Clin Proc 65:461-474
45. Blackwell RE 1985 Diagnosis and management of prolactinomas. Fertil Steril 43:5-16
46. Celotti F, Melcangi RC, Martini L 1992 The 5α-reductase in the brain: Molecular aspects and relation to brain function. Front Neuroendocrinol 13: 163-215
47. Carretero J, Vazquez G, Blanco E, Rubio M, Santos M, Martin Clavijo A, Torres JL, Vazquez R 1999 Immunohistochemical evidence of the presence of aromatase P450 in the rat hypophysis. Cell Tissue Res 295:419-423
48. Korach KS, Couse JF, Curtis SW, Washburn TF, Lindzey J, Kimbro KS, Eddy EM, Migliaccio S, Snedeker SM, Lubahn DB, Schomberg DW, Smith EP 1996 Estrogen receptor gene disruption: Molecular characterization and experimental and clinical phenotypes. Recent Prog Horm Res 51:159-186
49. Bocchinfuso WP, Lindzey JK, Hewitt SC, Clark JA, Myers PH, Cooper R, Korach KS 2000 Induction of mammary gland development in estrogen receptor-α knockout mice. Endocrinology 141:2982-2994
50. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA, Shyamala G, Conneely OM, O'Malley BW 1995 Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 9:2266-2278
51. Lydon JP, Ge G, Kittrell FS, Medina D, O'Malley BW 1999 Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res 59:4276-4284
52. Brisken C, Kaur S, Chavarria TE, Binart N, Sutherland RL, Weinberg RA, Kelly PA, Ormandy CJ 1999 Prolactin controls mammary gland development via direct and indirect mechanisms. Dev Biol 210:96-106
53. Vomachka AJ, Pratt SL, Lockefeer JA, Horseman ND 2000 Prolactin genedisruption arrests mammary gland development and retards T-antigen-induced tumor growth. Oncogene 19:1077-1084
54. Aldaz CM, Liao QY, LaBate M, Johnston DA 1996 Medroxyprogesterone acetate accelerates the development and increases the incidence of mouse mammary tumors induced by dimethylbenzanthracene. Carcinogenesis 17: 2069-2072
55. Lange CA, Richer JK, Horwitz KB 1999 Hypothesis: Progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals. Mol Endocrinol 13:829-836
56. Wennbo H, Gebre-Medhin M, Gritli-Linde A, Ohlsson C, Isaksson OG, Tornell J 1997 Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. J Clin Invest 100:2744-2751
57. Huseby RA, Soares MJ, Talamantes F 1985 Ectopic pituitary grafts in mice: Hormone levels, effects on fertility, and the development of adenomyosis uteri, prolactinomas, and mammary carcinomas. Endocrinology 116:1440-1448
58. Swanson SM, Guzman RC, Christov K, Miyamoto S, Nandi S 1994 Pituitary-isografted mice are highly susceptible to MNU-induced mammary carcinogenesis irrespective of the level of alveolar differentiation. Carcinogenesis 15:1341-1346
59. Hankinson SE, Willett WC, Michaud DS, Manson JE, Colditz GA, Longcope C, Rosner B, Speizer FE 1999 Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 91:629-634